Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial url: academic.oup.com/jid/article-...

A/Prof Ben Teh presenting his and NCIC PhD candidate Dr Tori Halls work on respiratory viruses in people with haem malignancy at #escmidglobal flash poster session. RSV in particular associated with more severe disease

Two patients with refractory myeloma who had excellent antitumor responses to cilta-cel CAR T-cell therapy later had T-cell lymphomas that contained the lentivirus construct used to generate the CAR T-cell product. Brief Report on the CARTITUDE-4 trial: nej.md/4gA6G27

#MedSky #Hematology

If you care for patients with suspected tuberculosis, this excellent online tool helps assess the risk of active TB disease and potential medication side effects.

Link: www.TSTin4D.com

From colleagues at McGill.

#IDSky #MedSky

Congratulations Tori!

💉 One flu shot is enough! New research from @benwteh.bsky.social & @victoriahall.bsky.social shows a single flu vaccine dose protects non-transplant blood cancer patients.

Simplified care + better vaccine use = big win for vulnerable patients!

Learn more: www.petermac.org/about-us/new...

Very proud of this hard work & team effort from all involved! Limited benefit of adjuvanted flu 💉 & 2 vs 1 dose in pts w/ MM, CLL or NHL. @ncicancer.bsky.social @petermaccc.bsky.social @benwteh.bsky.social @trubianojason.bsky.social @michyong.bsky.social @nejm.org www.nejm.org/doi/full/10....

Practice affirming results from our team @victoriahall.bsky.social @ncicancer.bsky.social - No additional benefit from second influenza vaccine dose/adjuvant vaccines in non-HCT haematology patients. #TxID #IDsky #medsky

www.nejm.org/doi/full/10....

Hello to the #IDSky and #TxIDSky community! AST IDCOP is excited to announce our presence on Bluesky. @astinfo.bsky.social